Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

124 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Nucleolin expression has prognostic value in neuroblastoma patients.
Cangelosi D, Brignole C, Bensa V, Tamma R, Malaguti F, Carlini B, Giusto E, Calarco E, Perri P, Ribatti D, Fonseca NA, Moreira JN, Eva A, Amoroso L, Conte M, Garaventa A, Sementa AR, Corrias MV, Ponzoni M, Pastorino F. Cangelosi D, et al. Among authors: eva a. EBioMedicine. 2022 Nov;85:104300. doi: 10.1016/j.ebiom.2022.104300. Epub 2022 Oct 6. EBioMedicine. 2022. PMID: 36209521 Free PMC article.
Hypoxia Predicts Poor Prognosis in Neuroblastoma Patients and Associates with Biological Mechanisms Involved in Telomerase Activation and Tumor Microenvironment Reprogramming.
Cangelosi D, Morini M, Zanardi N, Sementa AR, Muselli M, Conte M, Garaventa A, Pfeffer U, Bosco MC, Varesio L, Eva A. Cangelosi D, et al. Among authors: eva a. Cancers (Basel). 2020 Aug 19;12(9):2343. doi: 10.3390/cancers12092343. Cancers (Basel). 2020. PMID: 32825087 Free PMC article.
Exosomal microRNAs from Longitudinal Liquid Biopsies for the Prediction of Response to Induction Chemotherapy in High-Risk Neuroblastoma Patients: A Proof of Concept SIOPEN Study.
Morini M, Cangelosi D, Segalerba D, Marimpietri D, Raggi F, Castellano A, Fruci D, de Mora JF, Cañete A, Yáñez Y, Viprey V, Corrias MV, Carlini B, Pezzolo A, Schleiermacher G, Mazzocco K, Ladenstein R, Sementa AR, Conte M, Garaventa A, Burchill S, Luksch R, Bosco MC, Eva A, Varesio L. Morini M, et al. Among authors: eva a. Cancers (Basel). 2019 Sep 30;11(10):1476. doi: 10.3390/cancers11101476. Cancers (Basel). 2019. PMID: 31575060 Free PMC article.
Multiparametric flow cytometry highlights B7-H3 as a novel diagnostic/therapeutic target in GD2neg/low neuroblastoma variants.
Dondero A, Morini M, Cangelosi D, Mazzocco K, Serra M, Spaggiari GM, Rotta G, Tondo A, Locatelli F, Castellano A, Scuderi F, Sementa AR, Eva A, Conte M, Garaventa A, Bottino C, Castriconi R. Dondero A, et al. Among authors: eva a. J Immunother Cancer. 2021 Apr;9(4):e002293. doi: 10.1136/jitc-2020-002293. J Immunother Cancer. 2021. PMID: 33795387 Free PMC article.
CHL1 gene acts as a tumor suppressor in human neuroblastoma.
Ognibene M, Pagnan G, Marimpietri D, Cangelosi D, Cilli M, Benedetti MC, Boldrini R, Garaventa A, Frassoni F, Eva A, Varesio L, Pistoia V, Pezzolo A. Ognibene M, et al. Among authors: eva a. Oncotarget. 2018 May 25;9(40):25903-25921. doi: 10.18632/oncotarget.25403. eCollection 2018 May 25. Oncotarget. 2018. PMID: 29899830 Free PMC article.
124 results